Imagen de Portada

Supplementary materials: Subclassification-Specific Tumor Immune Microenvironment in Intrahepatic Cholangiocarcinoma: Implications for Appropriate Pharmacotherapy

Fuente: Zenodo

Guardado en:

Detalles Bibliográficos
Autor principal:	Kinoshita, Masahiko
Formato:	Recurso digital
Publicado:	Zenodo 2025
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Hyperspectral Imaging for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma Differentiation
por: Yunze Li, et al.
Publicado: (2025)

Single‐Cell and Spatial Transcriptomics Delineate the Microstructure and Immune Landscape of Intrahepatic Cholangiocarcinoma in the Leading‐Edge Area
por: Li Zuyin, et al.
Publicado: (2024)

Intravascular Large B‐Cell Lymphoma Mimicking Intrahepatic Cholangiocarcinoma
por: Seigi Oshima, et al.
Publicado: (2025)

KRAS Withdrawal in Cholangiocarcinoma Leads to Immune Infiltration and Tumor Regression
por: Youwei Qiao, et al.
Publicado: (2025)

Lightweight Spectral‐ MLP for Hyperspectral Differentiation of Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma
por: Qingyuan Zhang, et al.
Publicado: (2025)

Sunitinib in Advanced Intrahepatic Cholangiocarcinoma: Questions on Biomarkers, Imaging, and Combination Strategies
por: Huan Luo, et al.
Publicado: (2025)

lncRNA NKILA Promotes Warburg Effect and Immune Escape in Intrahepatic Cholangiocarcinoma by Regulating the MTX1/TOMM40 Axis
por: Meiying Zhu, et al.
Publicado: (2025)

Conversion Therapy for Locally Advanced Intrahepatic Cholangiocarcinoma: A Retrospective Cohort Study
por: Jienan Lu, et al.
Publicado: (2025)

Intrahepatic Cholangiocarcinoma Masquerading as Liver Abscess: A Case Report With Multimodal Imaging
por: Chunxiao Song, et al.
Publicado: (2025)

Intrahepatic Cholangiocarcinoma Surgery Outcomes and Survival Factors in an Opisthorchis viverrini ‐Endemic Area
por: Nisit Tongsiri, et al.
Publicado: (2026)

Zinc Finger Protein 263 Augments Autophagy and Promotes Intrahepatic Cholangiocarcinoma Proliferation
por: Zaihua Yan, et al.
Publicado: (2024)

Single‐Cell Transcriptomic Analysis Reveals an Aggressive Basal‐Like Tumor Cell Subpopulation Associated With Poor Prognosis in Intrahepatic Cholangiocarcinoma
por: Changyi Liao, et al.
Publicado: (2025)

Patient‐Derived 3D‐Bioprinted Intrahepatic Cholangiocarcinoma Models Recapitulate Tumor Autologous Traits and Predict Personalized Adjuvant Therapy
por: Yuce Lu, et al.
Publicado: (2026)

Role of Tunneling Nanotubes in Arachidonic Acid Transfer and Macrophage Function Reprogramming in Intrahepatic Cholangiocarcinoma
por: Meiru Chen, et al.
Publicado: (2025)

Cytologic Findings of Cholangioblastic Variant of Intrahepatic Cholangiocarcinoma: A Rare Variant and Cytologic Pitfall
por: Eleonora Fiorletta Quiroga, et al.
Publicado: (2025)

Can We Define a High‐Grade Precursor of Small Duct Intrahepatic Cholangiocarcinoma?
por: Shota Kobayashi, et al.
Publicado: (2025)

Establishment and Characterization of MCA23 , a Novel Mouse Intrahepatic Cholangiocarcinoma Cell Line
por: Yuchao He, et al.
Publicado: (2026)

Very Early Recurrence Following Liver Resection for Intrahepatic Cholangiocarcinoma: Is It Predictable by Clinical Preoperative Factors?
por: Francesco Ardito, et al.
Publicado: (2025)

Clonorchis sinensis Promotes Intrahepatic Cholangiocarcinoma Progression by Activating FASN‐Mediated Fatty Acid Metabolism
por: Xiaoxue Ren, et al.
Publicado: (2025)

The Biliary Stenting Strategy for the Unresectable Hilar Type of Intrahepatic Cholangiocarcinoma: A Single‐Center Experience
por: Cui Chen, et al.
Publicado: (2025)

Oncogenic Roles of Laminin Subunit Gamma‐2 in Intrahepatic Cholangiocarcinoma via Promoting EGFR Translation
por: Jianjuan Zhang, et al.
Publicado: (2024)

Tumor Microenvironment Specific Regulation Ca‐Fe‐Nanospheres for Ferroptosis‐Promoted Domino Synergistic Therapy and Tumor Immune Response
por: Xu Chu, et al.
Publicado: (2024)

Clinical Use of Comprehensive Genomic Profiling Tests in Intrahepatic Cholangiocarcinoma: A Single‐Center Retrospective Study
por: Makiko Urabe, et al.
Publicado: (2025)

RRM2 Promotes the Progression of Intrahepatic Cholangiocarcinoma by Inhibiting Ferroptosis Through the HIF ‐1α Pathway
por: Yinghui Song, et al.
Publicado: (2026)

Rising Mortality of Intrahepatic Cholangiocarcinoma Among Older Adults in the United States: An Analysis of Demographic and Regional Trends
por: Muhammad Ali Tariq, et al.
Publicado: (2024)

Synthetic Retinoid Sulfarotene Selectively Inhibits Tumor‐Repopulating Cells of Intrahepatic Cholangiocarcinoma via Disrupting Cytoskeleton by P‐Selectin/PSGL1 N‐Glycosylation Blockage
por: Xiaojing Du, et al.
Publicado: (2024)

The Immune Microenvironment: New Therapeutic Implications in Organ Fibrosis
por: Xiangqi Chen, et al.
Publicado: (2025)

Characteristics of “Very Early” Intrahepatic Cholangiocarcinoma Undergoing Liver Resection and Its Relationship With Carbohydrate Antigen 19‐9
por: Yutaka Endo, et al.
Publicado: (2025)

Intrahepatic Cholangiocarcinoma: Epidemiological Trends, Risk Factors, Diagnostic Challenges, and Advances in Personalized Therapy—A Comprehensive Review
por: Yaqoob Muhammad, et al.
Publicado: (2026)

DNA‐Loaded Nanoparticles Reprogram the Tumor Immune Microenvironment to Treat Brain Tumors
por: Joanna Yang, et al.
Publicado: (2026)

Engineered Nanomaterials for Tumor Immune Microenvironment Modulation in Cancer Immunotherapy
por: Hao Xing, et al.
Publicado: (2024)

Oxidative Stress in the Tumor Immune Microenvironment: Mechanisms and Therapeutic Perspectives
por: Zhen Wang, et al.
Publicado: (2026)

Sunitinib as Second‐Line Treatment in Advanced Intrahepatic Cholangiocarcinoma: Results From the SUN ‐ CK GERCOR Phase II Trial
por: Louis Gros, et al.
Publicado: (2025)

Association Between MRI‐Based Radiomics Features and Regional Lymph Node Metastasis in Intrahepatic Cholangiocarcinoma and Its Clinical Outcome
por: Xianling Qian, et al.
Publicado: (2024)

Comment On: “Preoperative Platelet Count as an Independent Predictor of Long‐Term Outcomes Among Patients Undergoing Resection for Intrahepatic Cholangiocarcinoma”
por: Qingqing Zhao, et al.
Publicado: (2024)

Development and Validation of a Predictive Risk Score for Blood Transfusion in Patients Undergoing Curative‐Intent Surgery for Intrahepatic Cholangiocarcinoma
por: Giovanni Catalano, et al.
Publicado: (2024)

Correction to “Sprouty2 Suppresses Progression and Correlates to Favourable Prognosis of Intrahepatic Cholangiocarcinoma via Antagonizing FGFR2 Signalling”
Publicado: (2026)

Tumor Anti‐Angiogenesis Therapy and Its Influence on Immune Cell Function in the Tumor Microenvironment
por: Yu Tang, et al.
Publicado: (2026)

Nanoparticle‐Mediated Tumor Microenvironment Remodeling Favors the Communication with the Immune Cells for Tumor Killing
por: Elena Lucena‐Sánchez, et al.
Publicado: (2024)

Bayesian-based Propensity Score Subclassification Estimator
por: Orihara, Shunichiro, et al.
Publicado: (2024)